Abstract
As cerebral mucormycosis is devastating in nature, here we discuss possible use of the intranasal route, in comparison to or in addition to intravenous administration, as a therapeutic approach to manage cases of mucormycosis with central nervous system involvement.
| Original language | English |
|---|---|
| Pages (from-to) | 299-301 |
| Number of pages | 3 |
| Journal | Current Medical Research and Opinion |
| Volume | 38 |
| Issue number | 2 |
| Early online date | 12 Nov 2021 |
| DOIs | |
| Publication status | Published - 1 Feb 2022 |
Fingerprint
Dive into the research topics of 'Cerebral mucormycosis: intranasal route to deliver amphotericin B for effective management?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver